1 result
-
Proposed extension of the abbreviated procedure for new medicine applications and section 24(5)(a) notifications
This consultation is aimed at pharmaceutical companies seeking to submit abbreviated applications to Medsafe for regulatory approval of new medicine products or changed medicine notifications. Medsafe is seeking your feedback on changes to these guidelines: Guideline on the Regulation of Therapeutic Products in New Zealand: New Medicine Applications Guideline on the Regulation of Therapeutic Products in New Zealand: Changed Medicine Notifications and... MoreCloses 13 March 2026
1 result.
Page 1 of 1